Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Oncology

Journal Scan / Research · January 16, 2023

Clinicopathological Characteristics and Response to Neoadjuvant Chemotherapy in HER2-Low vs HER2-Zero Breast Cancer

The Breast


Additional Info

The Breast
Comparison of clinicopathological characteristics and response to neoadjuvant chemotherapy between HER2-low and HER2-zero breast cancer
Breast 2023 Feb 01;67(xx)1-7, S Zhou, T Liu, X Kuang, T Zhen, H Shi, Y Lin, N Shao

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading